Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation

Lifeward Ltd. (LFWD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
Negative: The company's accumulated deficit of -$295.5M and consistent negative free cash flow suggest an imminent liquidity crisis that likely necessitates dilutive capital raises.
Lifeward Ltd. (LFWD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Lifeward Ltd. (LFWD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $6.70vs $1.18-467.8% | $4Mvs $6M-32.1% |
| Q2 2026 | Mar 18, 2026 | $3.60vs $0.84-328.6% | $5Mvs $8M-35.4% |
| Q4 2025 | Nov 14, 2025 | $0.20vs $0.09-122.2% | $6Mvs $8M-21.3% |
| Q3 2025 | Aug 14, 2025 | $0.58vs $0.25-132.0% | $6Mvs $7M-13.5% |
Recent stock market news and headlines for Lifeward Ltd. (LFWD)
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation

Key metrics vs top competitors for Lifeward Ltd. (LFWD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.20 | $11.6M | -0.42 | -14.14% | -90.38% | -146.12% | — | |
| $22.20 | $53.85M | -4.52 | -28.6% | -135.66% | -177.4% | — | |
| $0.05 | $1.72M | -0.01 | -23.44% | -38.16% | — | — | |
| $1.77 | $80.66M | -6.10 | — | -13535.24% | -21.84% | — | |
| $86.25 | $11.63B | 22.00 | 16.65% | 18.92% | 13.04% | — | |
| $15.43 | $1.76B | -12.65 | 8.28% | -25.66% | -50.82% | — |
Lifeward Ltd. (LFWD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Lifeward Ltd. (LFWD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 19, 2026·SEC
May 15, 2026·SEC
Apr 23, 2026·SEC
Get notified when LFWD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Lifeward Ltd. (LFWD) stock FAQ — growth, dividends, profitability & financials explained
Lifeward Ltd. (LFWD) reported $20.9M in revenue for fiscal year 2025. This represents a 257% increase from $5.9M in 2016.
Lifeward Ltd. (LFWD) saw revenue decline by 14.1% over the past year.
Lifeward Ltd. (LFWD) reported a net loss of $25.9M for fiscal year 2025.
Lifeward Ltd. (LFWD) has a return on equity (ROE) of -146.1%. Negative ROE indicates the company is unprofitable.
Lifeward Ltd. (LFWD) had negative free cash flow of $15.0M in fiscal year 2025, likely due to heavy capital investments.